Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)

SHA:688161 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	261.08	268.64	223.75	112.32	600.7	690.32
Depreciation & Amortization	60.21	60.21	64.84	62.4	56.91	51.48
Other Amortization	54.95	54.95	46	43.49	42.02	42.34
Loss (Gain) From Sale of Assets	-0.15	-0.15	-6.37	-0.02	-0.27	-0.03
Asset Writedown & Restructuring Costs	0.21	0.21	0.25	0.2	0.04	3.81
Loss (Gain) From Sale of Investments	-32.08	-32.08	-27.32	-27.69	-27.57	-22.78
Provision & Write-off of Bad Debts	7.63	7.63	-8.29	-5.29	15.02	10.13
Other Operating Activities	27.6	38.72	45.51	21.08	1.62	1.35
Change in Accounts Receivable	-65.35	-65.35	34.14	227.83	-105.88	-102.56
Change in Inventory	16.58	16.58	13.11	-160.54	-143.72	-49.72
Change in Accounts Payable	37.57	37.57	-111.36	-137.02	69.28	169.3
Change in Other Net Operating Assets	27.92	27.92	-	-	-	-
Operating Cash Flow	396.73	415.42	274.19	119.44	508.56	788.25
Operating Cash Flow Growth	25.99%	51.51%	129.56%	-76.51%	-35.48%	22.38%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-30.64	-27.09	-24.34	-42.98	-115.76	-112.41
Sale of Property, Plant & Equipment	1.31	14.65	0.57	2.08	1.41	0.21
Cash Acquisitions	-66.39	-	-	-43.22	-	-
Investment in Securities	-458.41	-638.5	-203	-20	-90	-1,090
Other Investing Activities	29.31	32.76	33.15	10.46	48.71	12.06
Investing Cash Flow	-524.82	-618.18	-193.62	-81.57	-129.46	-1,188

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	8.54	-	-	-
Long-Term Debt Repaid	-	-9.31	-5.71	-4.83	-4.85	-4.45
Net Debt Issued (Repaid)	-10.06	-9.31	2.83	-4.83	-4.85	-4.45
Issuance of Common Stock	-	-	-	-	-	1,405
Repurchase of Common Stock	-	-	-35	-45.01	-	-
Common Dividends Paid	-127.72	-127.69	-75.25	-163.99	-211.44	-
Other Financing Activities	-104.4	-103	-103	-710.54	-12.39	-46.58
Financing Cash Flow	-242.18	-239.99	-210.43	-924.36	-228.68	1,354

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-2.13	-0.87	0.92	0.18	-0.55	-0.09
Net Cash Flow	-372.4	-443.63	-128.93	-886.31	149.88	953.8

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	366.09	388.33	249.85	76.46	392.8	675.84
Free Cash Flow Growth	24.70%	55.42%	226.76%	-80.53%	-41.88%	13.68%
Free Cash Flow Margin	23.94%	25.50%	17.20%	5.96%	19.09%	31.38%
Free Cash Flow Per Share	0.91	0.97	0.63	0.19	0.98	1.78
Levered Free Cash Flow	33.94	323.26	125.96	452.76	230.39	488.41
Unlevered Free Cash Flow	34.61	323.87	126.61	453.36	230.78	488.79

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.84	0.84	0.23	0.21	0.54	-
Cash Income Tax Paid	213.22	204.04	162.21	233.32	328.76	368.51
Change in Working Capital	17.27	17.27	-64.17	-87.05	-179.91	11.63

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error